ASSOCIATION OF THE APOLIPOPROTEIN A-I GENE POLYMORPHISMS WITH CARDIOVASCULAR DISEASE RISK FACTORS AND ATHEROGENIC INDICES IN PATIENTS FROM ASSAM, NORTHEAST INDIA
Bora K1,2,*, Pathak MS2, Borah P3, Hussain Md.I.3, Das D4
*Corresponding Author: : Dr. Kaustubh Bora, Regional Medical Research Centre, Northeast Region, Indian Council of Medical Research (ICMR), P.O. Box 105, Dibrugarh-786001, Assam, India. Tel: +91-943-557-2062. Fax: +91-364-253-8003. E-mail: kaustubhbora1@gmail.com
page: 59

RESULTS

The baseline characteristics of the study subjects are presented in Table 1. The individuals in the case and the control groups were comparable (p >0.05) in terms of age and sex composition, and smoking and alcohol use status. Concentration of HDL-C was significantly lower in the case group than in the control group, as expected. Furthermore, the case group individuals had significantly higher (p <0.05) measures of obesity (BMI and WC), systolic and diastolic BP, lipid profile parameters (TC, TG, LDL-C and VLDL-C) and atherogenic indices in comparison to the control group individuals. None of the subjects in the study were vegetarians. During genotyping, we detected GG, GA and AA genotypes for the G-75A site, and CC and CT genotypes for the C+83T site (Figure 1). Distribution of G-75A and C+83T Single Nucleotide Polymorphisms. The genotype, allelic and diplotype frequencies for G-75A and C+83T polymorphic loci are summarized in Table 2. Both the polymorphisms were in Hardy-Weinberg equilibrium. For the G-75A site, the GG genotype was most common, followed by GA and AA. The frequencies of GG, GA and AA genotypes were comparable between the case and the control groups (χ2 = 1.692, df = 2, p = 0.43). The allelic frequencies in the two groups were also comparable (minor A allele frequency = 0.205 in cases and 0.235 in controls, χ2 = 0.364, df = 1, p = 0.55). For the C+83T site, the homozygous TT genotype was not detected in either the cases or the controls. However, the frequency of CC and CT genotypes were comparable in the two groups (χ2 = 0.047, df = 1, p = 0.83). Similarly, the minor T allele frequency (0.055 in cases and 0.065 in controls) was also comparable (χ2 = 0.044, df = 1, p = 0.83). Five diplotypes were detected for the two polymorphic sites (Table 2). The diplotype frequencies did not vary significantly between the case and the control groups (χ2 = 2.041, df = 4, p = 0.73). Association of G-75A and C+83T Single Nucleotide Polymorphisms with Decreased High Density Lipoprotein Cholesterol. Neither the genotypic variants nor the allelic variants of the G-75A or the C+83T polymorphism detected in the study were associated with HDL-C status (Table 3). Association of G-75A and C+83T Single Nucleotide Polymorphisms with Other Lipid Fractions. The G-75A SNP was associated with LDL-C levels (Table 4). Values of LDL-C were significantly (p <0.05) higher in the A allele-containing controls as compared to the GG homozygotes. No significant association (p >0.05) was observed with other components of lipid profile. The C+83T locus was associated with TG and VLDL-C levels (Table 5). The case subjects with the CC genotype had significantly (p <0.05) higher TG and VLDL-C values than their CT counterparts. These findings persisted in the overall sample. Association of G-75A and C+83T Single Nucleotide Polymorphisms with Atherogenic Indices. The G-75A polymorphism was associated with several atherogenic indices (Table 4). The AA homozygotes had significantly (p <0.05) elevated non-HDL-C and CRI-II values, whereas the G allele carriers had significantly (p <0.05) diminished CRI-I and AC values. On the other hand, the C+83T polymorphism was associated with the AIP values (Table 5). The CC subjects had significantly (p <0.05) raised AIP than their CT counterparts. Association of G-75A and C+83T Single Nucleotide Polymorphisms with Obesity Indices and Blood Pressure. The G-75A and C+83T loci were not associated with obesity and BP in the subjects under the present study. Values of WC, BMI and systolic and diastolic BP were comparable (p >0.05) across the different genotypes detected for the two polymorphic sites (Tables 4 and 5). Association of Diplotypes with the Cardiovascular Disease Risk Factors. The CVD risk factors did not differ significantly across the five diplotypes obtained in the current study (data not shown). Effect Size and Power. The G-75A locus produced medium-to-large sized effects (0.25 < Cohen’s f <0.4) on the CVD risk factors (non-HDL-C, CRI-I, CRI-II, AC and LDL-C values) with which it was associated, while the effect size of the C+83T locus on CVD risk factors (TG, VLDL-C and AIP) was small-to-medium (0.1



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006